CD4+CD8+ cells are present during T cell differentiation in the thymus. Less than 2% of normal T cells that coexpress CD4 and CD8 also are released in the circulation and are present in the peripheral blood. In this study, nine individuals are described that manifested persistent expansions (1 1 % to 43%) of circulating CD4+CD8+ T cells that in three cases had large granular lymphocyte (LGL) morphology in the absenceof either lymphocytosisorovertlymphoproliferative disorders. Southern blot hybridization of enriched CD4+CD8+ cells with T-cell receptor j3 (TCRj3) and TCRy probes showed that most cases had the 12-kb Eco RI germinal band deleted or of decreased intensity. In several individuals new TCRj3-specific bands of different intensity and distinct from case to case suggested either monoclonal or oligoclonal and polyclonal expansions. Immunophenotypic analysis showed that in 7 out of 9 cases ERIPHERAL BLOOD (PB) T cells typically express P high density of T-cell receptor (TCR)/CD3 complex and either CD4 or CD8 surface antigens. Both subsets of cells arise from precursor thymocytes after a maturation process in the cortex where most T lymphocytes simultaneously coexpress CD4 and CD8 antigens. Through a selection process taking place in the deep cortex and medulla of the thymus, T cells bearing only CD4 or CD8 are released in the circulation.' However, a very low percentage (1% to 2%) of T cells that coexpress CD4 and CD8 also are found in the PB. These mature T cells may represent intermediates between CD4+CD8+ thymocytes and mature CD4+CD8-or CD4-CD8+ cells. Alternatively, the CD4+CD8+ cells may originate from cells positive for only one of the markers that reacquire the expression of either CD8 or CD4.2
understand the clinico-biologic significance of expansions of such an unusual peripheral T-cell subset, we investigated the immunophenotype and the molecular structure of the TCR of the T cells expressing both CD4 and CD8.
MATERIALS AND METHODS

Donors.
Nine adults, eight females and one male, referred to the Clinical Chemistry Laboratory during the period May 1988 to February 199 1, were evaluated for PB mononuclear cells (PBMC) T-cell subsets as part ofa routine procedure. Approval was obtained from the Institutional Review Board for these studies. Informed consent was provided according to the Declaration of Helsinki. The main clinical and hematologic features at the time of the initial observation are reported in Table I . These individuals were examined over a period ranging from 13 to 45 months. On repeated observations the clinical and hematologic parameters, including absolute numbers of CD4+CD8+ T cells, have remained stable. A serologic survey to detect antibodies against toxoplasma and against several DNA viruses; cytomegalovirus (CMV); varicella; herpes viruses 1, 2, and 6; and hepatitis B and C; showed that several individuals had IgG but in no case IgM were detected suggesting that no infection was in an active state during the observation period. Only one individual (Z.D.) had IgG against hepatitis C. Notable was the high frequency of CMV-specific IgG (in 9 out of 9). Antibodies against both human T-cell lymphotropic virus type I (HTLV-I) and HTLV-I1 and against human immunodeficiency virus-1 (HIV-1) and HIV-2 were not detected. Furthermore, no autoantibodies against nuclear, mitochondrial, smooth muscle, and gastric parietal cell antigens were detected.
Lymphocyte preparation. PBMC were obtained after fractionation of heparinized venous blood on a lymphoprep (Ficoll separation solution, Seromed; Biochrom KG, Berlin, Germany) gradient. Cells at the interface were harvested, washed twice with phosphate buffered saline (PBS) containing 10% heat-inactivated normal rabbit serum (NRS) to reduce the possibility of aspecific binding to Fc receptors present at the cell surface, and analyzed within a few hours. Cell viability as evaluated by Trypan blue exclusion exceeded 95% in all the cases.
For single fluorescence analysis, 1 X IO6 cells in 50 pL of PBS containing 10% NRS and 0, 1% NaN, were incubated for 30 minutes at 4°C with saturating concentrations of each of the following fluorescein isothiocyanate (FITC)-or phycoerythrin (PE)-conjugated monoclonal antibodies (MoAbs): anti-CD 1 (Leu 6), anti-CD2 (Leu 5b), anti-CD3 (Leu 4), anti-CD4 (Leu 3a), anti-CD5 (Leu I), anti-CD7 (Leu 9), anti-CD8 (Leu 2a), anti-CD10 At the end of the incubation the cells were washed twice, resuspended, and immediately analyzed. For dual staining the same steps were followed, with the exception that cells were incubated with the appropriate associations of FITC-and PE-conjugated MoAbs. Triple labeling experiments were performed in the following way. Cells were incubated with biotin-conjugated anti-CD8 along with PE-and FITC-conjugated MoAbs. At the end of the incubation (30 minutes at 4°C) the cells were washed twice and then treated (30 minutes at 4°C) with the appropriate dilutions of Streptavidin-RED6 I3 (GIBCO BRL, Gaithersburg, MD). After two additional washes, the cells were resuspended in 0.5 mL of PBS containing 0.1 % NaN, , and immediately analyzed. Appropriate isotype-matched negative control MoAbs were used in all immunofluorescence experiments.
Flow-cytometry analysis. Terminal deoxynucleotide transferase (TdT) assessment. Expression of TdT was assessed by indirect immunofluorescence on PBMC obtained as above after cytocentrifugation and fixation in 95% methanol at 4°C for 30 minutes using as primary antibody a rabbit anticalf TdT IgG (Pharmacia, Uppsala, Sweden), and as secondary antibody an FITC-conjugated swine antirabbit Ig antiserum (Dakopatts A/S).
Enrichment of CD4'CD8+ cells. To enrich for CD4+CD8+ cells the MACS magnetic cell sorter (Becton Dickinson) was used. PBMC were incubated sequentially with biotin-labeled anti-CD8, followed by FITC-labeled avidin and finally with biotin microbeads. Labeled cells bound to the column were recovered and treated for 10 minutes with 50 mmol/L glycine, pH 3.5, to remove the anti-CD8 MoAb. Cells were then incubated with biotin-labeled anti-CD4 FITC-labeled avidin, biotin microbeads, and run through the column. Attached cells were recovered, reincubated with PEconjugated antLCD8 and the percentage of double-positive cells was determined. This procedure enriched CD4+CD8+ cells about twofold to fourfold.
DNA extraction and Southern blot analysis. High molecular weight genomic DNA was extracted from polymorphonuclear cells (PMN) and from PBMC by cell lysis, proteinase K digestion, extraction with phenol, and precipitation with ethanoLg DNA also was purified from enriched CD4+CD8+ T-cell populations. Ten micrograms of DNA were digested with the appropriate restriction endonuclease, subjected to electrophoresis in a 0.8% agarose gel, denatured, neutralized, transferred to a nitrocellulose filter, and hybridized to a T@' O or a Ty" probe and washed according to Southern.'
RESULTS
Surface-marker analysis.
During the course of routine immunophenotyping procedures we realized that in a low percentage of samples (<O. 1 %) obtained from individuals free of overt hematologic malignancies, the sum of their CD4+ and CD8' T cells exceeded 100%. This observation prompted us to investigate in more detail this phenomenon. As of the spring of 199 1, we have identified nine individuals, eight females and one male, that manifest a persistent expansion of their CD4+CD8+ T cells in the PB as evaluated by two-color combinations of MoAbs ( Table 1) . In five of these individuals, no enlarged lymphnodes nor any other pathologic feature on physical examination and/or underlying disorder were found. Amongst the remaining four subjects one was affected by a Down syndrome; one underwent surgery and chemotherapy for a mammary carcinoma; one had recurrent infections, and one had a HCV chronic hepatitis. CD4+CD8+ T cells detected at presentation accounted for 11% to 43% of total lymphocytes (absolute numbers: 0.29 to 1.1 1 X 109/L) and either remained stable or displayed minimal variations (< 10% of absolute numbers of CD4+CD8+ T cells for each subject) during the follow-up period ( Table 3 . Expression of CD4 and CD8 antigens on CD4+CD8+ T cells was characterized by the usual density of CD4 and "dim" density of CD8 molecule in 7 individuals, whereas in one (Z.D.) CD4 was associated with "bright" CD8. Another individual (D.W.E.) showed "bright" CD8 associated with "dim" CD4 (Fig 1) .
For comparison CD4+CD8+ T cells from normal healthy blood donors also were investigated. These cells displayed an heterogeneity in CD4 and CD8 surface antigen expression similar to that detected in the subjects with CD4+CD8+ expansions, with cells ranging from "dim" to "bright" fluorescence both for CD4 and CD8 molecules (Fig I , Nor) . To exclude the possibility that the double immunofluorescence detected on the PB T cells of the nine individuals was the consequence of CD4 or CD8 soluble antigens present in the serum and absorbed onto the cell surface of either CD4+ or of CD8' cells, PBMC were treated for IO minutes with 50 mmol/L glycine, pH 3.5, and then processed for immunofluorescence analysis. No difference both in percentage of double-positive cells nor in relative antigen intensity compared with untreated cells was detected (data not shown), suggesting that cells coexpressing CD4 and CD8 antigens did so because they synthesized both molecules.
Three-color fluorescent staining was applied to further explore the immunophenotype of CD4+CD8+ cells (Table  4 ). This analysis showed that 100% cells of all nine individuals were negative for CDl whereas they expressed high levels of several T-cell-specific markers such as CD2, CD5, and the complex CD3-TCR, whereas CD7 was present at low levels. These cells did not expressCD10 (common acute lymphoblastic leukemia antigen [CALLA]), TCRy6 or TdT (data not shown). The activation markers CD25 (IL-2 receptor), CD38, HLA-DR, the proliferation marker CD7 1, and the natural killer (NK) cells marker CD I6 were absent from the expanded CD4+CD8+ cells. Notable was the expression of CD56 and CD57 in a high percentage of cells of several donors. CD56 and CD57 markers also were expressed in a fraction of the rare CD4+CD8+ cells present in the PB of normal healthy blood donors. CD29 was highly expressed in CD4+CD8+ cells of all nine subjects. Furthermore, nearly 100% of the cells from four subjects expressed the memory T cell CD45RO marker alone whereas both CD45RO and virgin T cell CD45RA were coexpressed in the remainders (Fig 2) .
TCR gene analysis. To assess the possible clonal nature of the T cell expansions we initially performed Southern blot analysis on isolated DNA extracted from total PBMC of six individuals. The samples were tested with a DNA probe specific for the TCRP gene following Eco RI and Hind 111 restriction enzyme analysis. Compared with the control germline DNA, 4 out of 6 samples seemed to present faint additional nongermline bands (data not shown). To augment the possibility of detecting rearranged components, DNA extracted from CD4+CD8+ enriched T-cell preparations was investigated by Southern blot hybridization using DNA probes specific for the TCRP and TCRy The samples were analyzed by single fluorescence and the numbers refer to the percentage of positive cells.
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genes. In all cases TCRy gene was found in its germline configuration (data not shown). In contrast, we detected TCRP gene deletions or rearrangements in all nine cases. The 12.0-kb Eco RI band appeared deleted or faint in 8 out of 9 samples (except no. 6, B.R.) (Fig 3A) . In several cases additional bands also were visible, and in two cases (no. 5, S.G. and no. 6, B.R.) a single major novel band was detected. The same DNAs were digested with the Hind 111 restriction enzyme and in 8 out of 9 samples (except no. 3, V.L.)asingle(no. 5,S.G.andno. 8,Z.D.),afew(no.6,B.R. and no. 9, D.W.E.), or several faint additional bands were detected (Fig 3B) . Overall, the results suggest that these cases fall within a spectrum of TCRP gene rearrangements indicative of monoclonal, oligoclonal, or policlonal CD4+CD8+ T-cell proliferations.
DISCUSSION
In this study we report on the presence of persistent expansions of peripheral T cells exhibiting the unusual CD4+CD8+ phenotype in nine individuals. Previous investigations have shown that normal healthy donors have a low proportion (1% to 2%) of peripheral CD4+CD8+ cells.* Apart from patients with lymphoblastic leukemia or lymphoma,12 few HTLV-I adult T-cell leukemias/lymphomas,I3 the rare Behcet's syndrome? and myastenia gravis,' elevated levels of CD4+CD8+ cells have previously been reported in one apparently normal adult male.6 Some of our subjects have been under investigation for more than 3 years by now and we have thus far not been able to detect significant changes in their physical status or laboratory findings that might suggest a neoplastic clonal evolution. Furthermore, 13 patients were recently described that present persistent expansions of CD4+CD8+ cells.' Their genotypic and immunophenotypic patterns were similar with our cases (some had rearranged TCRP or TCRP and y components, in all there was no evidence of activation antigens but they coexpressed CD56 and CD57 antigens). In the present series, at least one (S.G.), but probably a second (Z.D.) individual seem to have a single monoclonal rearranged TCRP band, whereas clear oligoclonal rearranged bands were detected in three additional cases. In the others the results were compatible with oligoclonal or more likely with polyclonal expansion^.'^ The persistence ofthe germ line bands (7.0 kb and 12.0 kb for the DNA digested with Hind 111 and Eco RI, respectively) in most samples might be explained by the presence of contaminating cells within the enriched CD4+CD8+ population, or more likely, by the predominant monoallelic nature of these rearrangements. A group of patients with lymphocytosis and LGL expansions was reported whose cells were found to express a very restricted VP gene repertoire.* Among those patients, two had the unusual CD4+CD8+ phenotype, presented a monoclonal rearrangement, and expressed the VP, variable region. The possibility that both in the present series and in that of Richards the rearranged bands might indicate limited VP gene usage also should be kept in mind. Because the pattern of VP families used by the rare CD4+CD8+ cells present in normal donors' PB is not available at the moment, this possibility remains to be investigated.
The majority of the patients described by Richards had lymphocytosis and/or increased proportions of lymphoFor personal use only. on November 11, 2017. by guest www.bloodjournal.org From cytes with distinct granular morphology (LGL) . still few patients had absolute lymphocyte numbers within normal limits and were similar to the present cases. Among our series only three individuals presented with expansions ofmorphologically distinct LGL cells whereas in the others the expanded cell population had a small lymphocyte morphology. It seems likely that the group studied in this report falls within a large spectrum of heterogeneous lymphoproliferative disorders with or without TCR clonal rearrangement including individuals with normal blood counts and moderate CD4TD8' expansions with or without LGL morphology and individuals with lymphocytosis and LGL morphology.
The immunophenotypic analysis performed on the CD4TD8' expanded cells in conjunction with the comparative analysis of PB CD4'CDS' cells of normal blood donors suggests few comments on their possible cellular origin. The CD45 thyrosine phosphatase family is comprised of at least five variants generated by alternative ~p l i c i n g '~. '~ that delineate maturational status: thus. cells expressing the high molecular mass CD45RA variant represent naive cells. whereas those lacking CD45RA and expressing high levels ofCD45RO represent memory cells." The expression of the two antigens on normal PB T cells. including the CD4+CD8+ fraction, is largely reciprocal but a transitional state characterized by CD45RATD45RO' expression has been described.18.19 Accordingly, we found five individuals in which the expression ranged from CD45RO-high and CD45RA-intermediate to CD45RO-intermediate and 5 6 7 8
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CD45RA-high suggesting that these lymphoid populations might be "frozen" during transition from a CD45RATD45RO-naive to a CD45RATD45RO' memory status. It has been reported that following "in vitro" activation of PB T cells a high number of CD4+CD8+ cells are generated that coexpress activation antigens such as CD25.2 These cells seem clearly distinct from the naturally expanded CD4+CD8+ cell populations of the present and previous report^.^.' Although a fraction of PB CD4+CD8+ T cells from normal healthy blood donors expressed HLA-DR, CD38. and CD7 I antigens: CD4'CD8' expansions did not express HLA-DR, CD38. CD71, or CD25. However, the low expression of CD7 and the high expression of CD29 suggests that these cells are to a certain extent activated and endowed with increased responsiveness to antigen and adhesion to a variety of ligands.20.21 The CD4'CD8+ expansions, albeit heterogeneous, might represent a preneoplastic or a nonneoplastic expansion of normal CD4TD8' cells with a certain phenotype "frozen" for some yet unknown events. A second possibility. as in the case of lectin activated PB T c e k 2 is that the CD4+CD8+ expansions might arise from either CD4TD8-or CD4-CD8' cells. For instance, it has been reported that CD8' T lymphocytes can reacquire CD4 expression after infection with human herpes virus 6 (HHV-6).22 Alternatively, CD4+ cells might have been induced to coexpress CD8 gene products as has been shown to occur when CD4' cells are maintained in vitro in the presence of IL-4.23 However. the high expression of CD57 in 8
For personal use only. on November 11, 2017. by guest www.bloodjournal.org From out of our 9 individuals and of CD56 in 5 is consistent with the notion that CD56 and CD57 antigens can be expressed on CD8+ cells, whereas, expecially the former, is absent from CD4+ cells. Similarly, CD4+CD8+ cells from normal blood donors are largely negative for both CD56 and CD57. On the other hand, these two antigens were present in the CD4+CD8-fraction from subjects with CD4+CD8+ expansions and LGL morphology' (and our additional phenotypic studies not shown) suggesting that in those individuals also the CD4+CD8-fraction might be unusual.
In conclusion, we have identified several cases with persistent CD4+CD8+ T-cell expansions of monoclonal, oligoclonal, or still polyclonal origin. The clinical significance of large numbers of circulating CD4+CD8+ cells is far from being clear. They might represent either a pre-neoplastic condition analogous to the angioimmunoblastic lymphadenopathyZ4 or the manifestation of an enhanced or abnormal immune reactivity. In this context, oligoclonal TCR gene rearrangements were reported in patients with acute Epstein-Barr virus (EBV)-induced infectious mononucleosis that is a benign self-limited diseasez5 and in patients with rheumatoid arthritis.26 Additional molecular and functional studies will help address the nature and determine the true significance of the expansions we observed and put them in the wider perspective of a continuum of similar or partly overlapping abnormalities.
